Pharma embraces open source models
Author:
- Stephen StraussSSStephen Strauss
- 1 July 2010
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 28 (7) , 631-633
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Thousands of chemical starting points for antimalarial lead identificationNature, 2010
- Arguments Against Precompetitive CollaborationClinical Pharmacology & Therapeutics, 2010
- The Biomarkers Consortium: Practice and Pitfalls of Open-Source Precompetitive CollaborationClinical Pharmacology & Therapeutics, 2010
- Research at the interface of industry, academia and regulatory scienceNature Biotechnology, 2010
- How to improve R&D productivity: the pharmaceutical industry's grand challengeNature Reviews Drug Discovery, 2010
- Is open innovation the way forward for big pharma?Nature Reviews Drug Discovery, 2010
- €2 billion IMI launched with European pharmaNature Biotechnology, 2008